BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26555370)

  • 1. Bioengineered heparins and heparan sulfates.
    Fu L; Suflita M; Linhardt RJ
    Adv Drug Deliv Rev; 2016 Feb; 97():237-49. PubMed ID: 26555370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering.
    Suflita M; Fu L; He W; Koffas M; Linhardt RJ
    Appl Microbiol Biotechnol; 2015 Sep; 99(18):7465-79. PubMed ID: 26219501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis.
    Chappell EP; Liu J
    Bioorg Med Chem; 2013 Aug; 21(16):4786-92. PubMed ID: 23313092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatic Synthesis of Glycosaminoglycans.
    Zhang X; Lin L; Huang H; Linhardt RJ
    Acc Chem Res; 2020 Feb; 53(2):335-346. PubMed ID: 31714740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.
    Powell AK; Yates EA; Fernig DG; Turnbull JE
    Glycobiology; 2004 Apr; 14(4):17R-30R. PubMed ID: 14718374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production methods for heparosan, a precursor of heparin and heparan sulfate.
    Chavaroche AA; van den Broek LA; Eggink G
    Carbohydr Polym; 2013 Mar; 93(1):38-47. PubMed ID: 23465899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
    Hu P; Fang L; Chess EK
    Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic synthesis of heparan sulfate and heparin.
    Liu J; Linhardt RJ
    Nat Prod Rep; 2014 Dec; 31(12):1676-85. PubMed ID: 25197032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides.
    Karst NA; Linhardt RJ
    Curr Med Chem; 2003 Oct; 10(19):1993-2031. PubMed ID: 12871100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-protein interactions.
    Capila I; Linhardt RJ
    Angew Chem Int Ed Engl; 2002 Feb; 41(3):391-412. PubMed ID: 12491369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?
    Farrugia BL; Lord MS; Melrose J; Whitelock JM
    Molecules; 2015 Mar; 20(3):4254-76. PubMed ID: 25751786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic heparin and heparan sulfate: probes in defining biological functions.
    Tsai CT; Zulueta MML; Hung SC
    Curr Opin Chem Biol; 2017 Oct; 40():152-159. PubMed ID: 29032302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights.
    Coombe DR; Kett WC
    Cell Mol Life Sci; 2005 Feb; 62(4):410-24. PubMed ID: 15719168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors.
    Kim HN; Whitelock JM; Lord MS
    Molecules; 2017 May; 22(5):. PubMed ID: 28505124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered heparins as new anticoagulant drugs.
    Vaidyanathan D; Williams A; Dordick JS; Koffas MAG; Linhardt RJ
    Bioeng Transl Med; 2017 Mar; 2(1):17-30. PubMed ID: 28516163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting heparin and heparan sulfate protein interactions.
    Weiss RJ; Esko JD; Tor Y
    Org Biomol Chem; 2017 Jul; 15(27):5656-5668. PubMed ID: 28653068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity.
    Sterner E; Li L; Paul P; Beaudet JM; Liu J; Linhardt RJ; Dordick JS
    Anal Bioanal Chem; 2014 Jan; 406(2):525-36. PubMed ID: 24271188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.
    Warda M; Mao W; Toida T; Linhardt RJ
    Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of low-molecular-weight heparin/heparan sulfate from marine sources.
    Saravanan R
    Adv Food Nutr Res; 2014; 72():45-60. PubMed ID: 25081076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.